ArcticZymes Technologies ASA (LON:0DRV)
London flag London · Delayed Price · Currency is GBP · Price in NOK
16.20
0.00 (0.00%)
At close: Jul 10, 2025

ArcticZymes Technologies ASA Company Description

ArcticZymes Technologies ASA, a life sciences company, develops, manufactures, and commercializes recombinant enzymes for use in molecular research, in vitro diagnostics, and biomanufacturing in Norway, Germany, Lithuania, France, Italy, the United Kingdom, rest of Europe, the United States, and internationally.

The company offers shrimp alkaline phosphatase for cleanup prior to Sanger sequencing and next generation sequencing processes; cod UNG for use in viral and other molecular diagnostic assays for the removal of contaminating dU-DNA; salt active nucleases for the removal of nucleic acids during manufacturing of viral vectors, recombinant proteins, and other reagents; and double-strand specific DNases and derived kits for the removal of double stranded DNA.

It also provides DNA/RNA polymerases for technology development for life science, molecular diagnostics, NGS, and synthetic biology; proteinase for microbiological diagnostics and liquid biopsies; and ligases for joining nucleic acids.

The company serves the molecular tools, such as research and diagnostics, and biomanufacturing markets.

The company was formerly known as Biotec Pharmacon ASA and changed its name to ArcticZymes Technologies ASA in June 2020.

ArcticZymes Technologies ASA was founded in 1990 and is headquartered in Tromsø, Norway.

ArcticZymes Technologies ASA
Country Norway
Founded 1990
Industry Biological Products, Except Diagnostic Substances
Employees 54
CEO Michael Akoh

Contact Details

Address:
Sykehusveien 23
Tromsø, 9294
Norway
Phone 47 77 64 89 00
Website arcticzymes.com

Stock Details

Ticker Symbol 0DRV
Exchange London Stock Exchange
Fiscal Year January - December
Reporting Currency NOK
ISIN Number NO0010014632
SIC Code 2836

Key Executives

Name Position
Michael Benjamin Akoh Chief Executive Officer
Borge Sorvoll Chief Financial Officer
Dr. Marit Sjo Lorentzen Vice President of Operations
Dr. Jeremy Gillespie Vice President of Corporate Development and Product Management
Paul Blackburn Ph.D. Vice President of Sales
Ruth Hendus-Altenburger PMO Manager